Authors: Jian Lu, Yongdong Zhou, Xiaojing Lin, Yongzhen Jiang, Ruiguang Tian, Yonghui Zhang, Jia Wu, Fengwei Zhang, Yong Zhang, Yue Wang, Shengli Bi
DOI: 10.1371/journal.pone.0008467
Abstract Summary
A comprehensive study of 8,762 Chinese subjects reveals encouraging progress in hepatitis control. Hepatitis B prevalence dropped to 5.84% overall and just 1.16% in children under 5, demonstrating vaccine program success. However, Hepatitis C rates (0.58%) were lower than WHO estimates, while Hepatitis A and E antibodies were detected in 72.87% and 17.66% of subjects respectively, suggesting widespread natural immunity.
Why Brain? ðŸ§
China’s hepatitis study of 8,762 subjects shows HBV vaccination reducing carriers in children under 5, but coverage gaps remain. HCV prevalence lower than WHO estimates at 0.58%.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
